Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Martínez-Sámano J et al. | 2018 | - | magnetic field, 50/60 Hz | - |
| Merla C et al. | 2019 | - | 50/60 Hz, magnetic field | - |
| Mohamad EA et al. | 2025 | mouse/Swiss injected with Ehrlich tumor carcinoma cells | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Morabito C et al. | 2010 | intact cell/cell culture, C2C12 cells (undifferentiated myoblasts and differentiated myotubes) | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
| Morabito C et al. | 2024 | animal, C57BL/6 mouse | magnetic field, 50/60 Hz | - |
| Mustafa E et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | 50/60 Hz, magnetic field | - |
| Muti ND et al. | 2023 | intact cell/cell culture, human spermatozoa | magnetic field, 50/60 Hz, low frequency | - |
| Naarala J et al. | 2017 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC), C6 cells (rat glioma cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, shielding/field deprivation | 0.2–120 µT |
| Nakayama M et al. | 2016 | intact cell/cell culture, macrophages (RAW 246) | magnetic field, 50/60 Hz, co-exposure | 500 µT |
| Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
